Laboratoires d'Anjou

Laboratoires d'Anjou is a French dermo-aesthetic company founded in 2001 by Carole Foussé, specializing in "medicalized beauty" under the brand CEBELIA. The company develops high-tolerance skincare products designed to accompany and optimize the results of aesthetic medical procedures such as lasers, peelings, and injections. Their portfolio is built around patented active ingredients like Cebeline, a laminin-5 peptide fragment for skin repair, and Pekaline, a patented molecule for treating hyperpigmentation, both developed in collaboration with major French research institutions like CNRS and INSERM. Laboratoires d'Anjou serves a global market of dermatologists, aesthetic physicians, and surgeons, providing solutions for post-procedure recovery and daily skin maintenance.